Medcast news and blog

Eating Disorders in General Practice

Eating disorders are truly holistic, affecting all biopsychosocial dimensions of health so we need to keep an open mind and our antennae alert in a wide variety of clinical scenarios in General Practice.

READ ON

Recent articles

Treatment burdens and time to do a bit more… nothing?
Treatment burdens and time to do a bit more… nothing?

We want to DO something for our patients, in part driven by guidelines - get their blood pressure down, improve their HbA1c, improve their life expectancy, but have we forgotten to ask - is this what you really want? And at what point are we doing more harm than good with the treatments we prescribe?

READ ON
Measles: Rare, but Still There
Measles: Rare, but Still There

Thankfully, Australian doctors nowadays will rarely see a case measles. Recently however, most states have issued measles outbreak alerts, largely linked to travellers visiting or returning from overseas.

READ ON
Hearing Loss in Adults: Assessment and Management
Hearing Loss in Adults: Assessment and Management

There is a tendency to consider hearing loss a wasted consultation, a referral wasted time. But hearing loss leads to marked isolation, significant reduction in quality of life and has a huge economic impact.

READ ON
Is it time to put a CAP on the number of PSA screening tests we are doing?
Is it time to put a CAP on the number of PSA screening tests we are doing?

'All screening programmes do harm; some do good as well, and, of these, some do more good than harm at reasonable cost’.

READ ON
Adding mirtazapine to SSRIs or SNRIs... does it work?
Adding mirtazapine to SSRIs or SNRIs... does it work?

Imagine you are seeing Sue with major depression. You have referred her for talking therapy, tried a SSRI then an SNRI and she is still no better. What next? Is it worth adding in mirtazapine?

READ ON
Where is the evidence...?
Where is the evidence...?

Although evidence-based medicine has undoubtedly been a force for good and has transformed clinical practice for the better, it has also been responsible for a subtle change in power dynamics when it comes to clinical policymaking.

READ ON
KISS: Mycoplasma genitalium
KISS: Mycoplasma genitalium

There’s been increasing attention on the little known organism Mycoplasma genitalium as an emerging cause of sexually transmitted conditions in women and men.

READ ON
Cardiovascular outcome data in type 2 diabetes, does it really matter to me and my patients?
Cardiovascular outcome data in type 2 diabetes, does it really matter to me and my patients?

So, we’ve heard about all this recent “exciting” cardiovascular outcome data in type 2 diabetes, but is there a real tangible benefit to our own patients outside of a clinical trial setting? How should we be incorporating it into our own clinical practice?

READ ON
Update on practical issues when prescribing PPIs
Update on practical issues when prescribing PPIs

Two of the five available PPIs rank in the top five medicines by prescription volume in the latest statistics from the Pharmaceutical Benefits Scheme (PBS) for prescriptions in 2016–17 and four of the five available PPIs are among the top 30 medicines.

READ ON